ArticleThe Journal of urology2024
Reply: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.
Marc B Garnick et al.PubMed ↗Publisher ↗
No numbers read from the abstract.